Cargando…

FOXO4 May Be a Biomarker of Postmenopausal Osteoporosis

PURPOSE: Postmenopausal osteoporosis (PMOP) is a common and debilitating chronic disease, but it has just no cure options. The objective of this study was to identify genes associated with osteoporosis and reveal potential therapeutic targets. METHODS: Expression profiles from GSE13850 and GSE56815...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Weiwei, He, Qing, Hu, Zhaohui, Xie, Xiangtao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786351/ https://www.ncbi.nlm.nih.gov/pubmed/35082523 http://dx.doi.org/10.2147/IJGM.S347416

Ejemplares similares

Identification of gene biomarkers in patients with postmenopausal osteoporosis
por: Yang, Chenggang, et al.
Publicado: (2019)

Serum C-C Motif Ligand 11/eotaxin-1 May Serve as a Candidate Biomarker for Postmenopausal Osteoporosis
por: Wang, Wen, et al.
Publicado: (2019)

Adiponectin as a Biomarker of Osteoporosis in Postmenopausal Women: Controversies
por: Lubkowska, Anna, et al.
Publicado: (2014)

Postmenopausal Osteoporosis
por: Kamel, Hosem K.
Publicado: (2006)

The Potential Role of Serum IGF-1 and Leptin as Biomarkers: Towards Screening for and Diagnosing Postmenopausal Osteoporosis
por: Zhang, Yili, et al.
Publicado: (2022)

Identification of ferroptosis-associated biomarkers for the potential diagnosis and treatment of postmenopausal osteoporosis
por: Hu, Yunxiang, et al.
Publicado: (2022)

Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review
por: Migliorini, Filippo, et al.
Publicado: (2021)

Botanicals in Postmenopausal Osteoporosis
por: Słupski, Wojciech, et al.
Publicado: (2021)

Association of dyslipidaemia with osteoporosis in postmenopausal women
por: Zhang, Lingnan, et al.
Publicado: (2021)

MicroRNAs in Serum Exosomes as Circulating Biomarkers for Postmenopausal Osteoporosis
por: Shi, Hongli, et al.
Publicado: (2022)

Biomarkers of postmenopausal osteoporosis and interventive mechanism of catgut embedding in acupoints
por: Chen, Guizhen, et al.
Publicado: (2020)

Yeast Hydrolysate and Postmenopausal Osteoporosis
por: Hong, Yang Hee, et al.
Publicado: (2023)

Effects of Yogasanas on osteoporosis in postmenopausal women
por: Motorwala, Zainab S, et al.
Publicado: (2016)

Risk Factors for Osteoporosis in Postmenopausal Women
por: Bijelic, Radojka, et al.
Publicado: (2017)

Alendronate improves QOL of postmenopausal women with osteoporosis
por: Kawate, Hisaya, et al.
Publicado: (2010)

Gingival recession in postmenopausal women with and without osteoporosis
por: DUNCEA, IOANA, et al.
Publicado: (2013)

Discovery of Potential Biomarkers for Postmenopausal Osteoporosis Based on Untargeted GC/LC-MS
por: Kou, Jun, et al.
Publicado: (2022)

Thoracolumbar kyphosis in postmenopausal osteoporosis patients without vertebral compression fractures
por: Guo, Rui, et al.
Publicado: (2022)

Bazedoxifene for the prevention of postmenopausal osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2008)

Intravenous bisphosphonates for postmenopausal osteoporosis
por: Mottaghi, Peyman
Publicado: (2010)

Treatment options for postmenopausal osteoporosis
por: Walsh, Garry M
Publicado: (2012)

Postmenopausal osteoporosis: Our experience
por: Mehrotra, R. N., et al.
Publicado: (2012)

Primary osteoporosis in postmenopausal women
por: Ji, Meng-Xia, et al.
Publicado: (2015)

MiR-422a as a Potential Cellular MicroRNA Biomarker for Postmenopausal Osteoporosis
por: Cao, Zheng, et al.
Publicado: (2014)

The role of melatonin in the development of postmenopausal osteoporosis
por: Yang, Keda, et al.
Publicado: (2022)

Do We Use Methylation of NFATC1 and FOS Genes As a Biomarker for Postmenopausal Osteoporosis?
por: Kalkan, R, et al.
Publicado: (2021)

Efficacy and Mechanisms of Oleuropein in Postmenopausal Osteoporosis
por: Liu, Huilan, et al.
Publicado: (2022)

Identification of ROCK1 as a novel biomarker for postmenopausal osteoporosis and pan-cancer analysis
por: Lai, Bowen, et al.
Publicado: (2023)

Ubiquitylomes Analysis of the Whole blood in Postmenopausal Osteoporosis Patients and healthy Postmenopausal Women
por: Yang, Yi‐ran, et al.
Publicado: (2019)

Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain
por: Darbà, Josep, et al.
Publicado: (2015)

Prescreening for Osteoporosis With Quantitative Ultrasound in Postmenopausal White Women
por: Steiner, Bernhard, et al.
Publicado: (2018)

Responsiveness of the Japanese Osteoporosis Quality of Life questionnaire in women with postmenopausal osteoporosis
por: Urushihara, Hisashi, et al.
Publicado: (2014)

Awareness of osteoporosis in postmenopausal Indian women: An evaluation of Osteoporosis Health Belief Scale
por: Gopinathan, Nirmal Raj, et al.
Publicado: (2016)

Postmenopausal Osteoporosis: A Literature Review
por: Bhatnagar, Aayushi, et al.
Publicado: (2022)

Construction of an miRNA-Regulated Pathway Network Reveals Candidate Biomarkers for Postmenopausal Osteoporosis
por: Shao, Min
Publicado: (2017)

Is grand multiparity a risk factor for the development of postmenopausal osteoporosis?
por: Peker, Nuri, et al.
Publicado: (2018)

LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
por: Yu, Haotao, et al.
Publicado: (2019)

Applying vibration in early postmenopausal osteoporosis promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells and suppresses postmenopausal osteoporosis progression
por: Li, Huiming, et al.
Publicado: (2019)

Serum Bisphenol A Concentration in Postmenopausal Women with Osteoporosis
por: Kim, Dong Hyun, et al.
Publicado: (2012)

MiR-133a in Human Circulating Monocytes: A Potential Biomarker Associated with Postmenopausal Osteoporosis
por: Wang, Yang, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1d3crp0pacevnemtvl2qs01pe1